FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

38620611000001104: Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jul 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1393251000001116 Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1393261000001118 Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) Is a Carbocisteine 250mg/5ml oral solution sugar free true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) Has specific active ingredient Carbocisteine true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) 300 ml Has AMP True Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start